News Releases
August 6, 2026
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community